Trial intelligence / Profile preview

Tranexamic Acid Irrigation to Reduce Blood Loss During Percutaneous Nephrolithotomy

TCTR20200612002Recruiting

Sponsor
N/A
Start
Jun 2020
Modality
Small Molecules
Countries
1
01

Overview

Randomised trial of tranexamic acid in nephrolithiasis (2 arms), sponsored by N/A. Primary endpoint: Perioperative blood loss. Started Jun 2020; status: recruiting.

02

Drugs

tranexamic acid
03

Conditions

nephrolithiasis

Beyond the preview

Go deeper on TCTR20200612002.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20200612002.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call